Net Income (Quarterly) Chart

Historical Net Income (Quarterly) Data

View and export this data back to 2011. Start Trial.
Date Value
March 31, 2026 -0.1662M
December 31, 2025 1.113M
September 30, 2025 -0.0854M
June 30, 2025 -0.2222M
March 31, 2025 -0.1584M
December 31, 2024 -0.1937M
September 30, 2024 -0.147M
June 30, 2024 -0.5915M
March 31, 2024 -0.2285M
December 31, 2023 -0.2493M
September 30, 2023 -0.157M
June 30, 2023 -0.2428M
March 31, 2023 -0.2136M
December 31, 2022 -0.1281M
September 30, 2022 -0.1928M
March 31, 2022 -0.6095M
December 31, 2021 -1.801M
September 30, 2021 -0.3313M
June 30, 2021 -0.1809M
March 31, 2021 -0.0492M
December 31, 2020 -0.0363M
September 30, 2020 -0.0027M
June 30, 2020 -0.0339M
March 31, 2020 -0.0027M
December 31, 2019 -0.0112M
Date Value
September 30, 2019 -0.0041M
June 30, 2019 -0.0133M
March 31, 2019 -0.0075M
December 31, 2018 -0.0365M
September 30, 2018 -0.0076M
June 30, 2018 -0.0215M
March 31, 2018 -0.0091M
December 31, 2017 -0.0151M
September 30, 2017 -0.0137M
June 30, 2017 -0.0362M
March 31, 2017 -0.0121M
December 31, 2016 -0.8607M
September 30, 2016 0.00
June 30, 2016 0.00
March 31, 2016 0.00
December 31, 2015 -0.115M
September 30, 2015 -0.693M
June 30, 2015 -0.1829M
March 31, 2015 -0.1588M
December 31, 2014 -0.1596M
September 30, 2014 -0.1588M
June 30, 2014 -0.1517M
March 31, 2014 -0.1517M
December 31, 2013 -0.0499M
September 30, 2013 -0.0221M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (Quarterly) Range, Past 5 Years

View Net Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Quarterly) Benchmarks

View Net Income (Quarterly) Benchmarks
Start Trial
AbbVie, Inc. 3.604B
Abeona Therapeutics, Inc. -20.19M
Acumen Pharmaceuticals, Inc. -32.72M
Abpro Holdings, Inc. -0.94M
Aardvark Therapeutics, Inc. -14.39M

Net Income (Quarterly) Related Metrics